Works matching IS 00207136 AND DT 2022 AND VI 151 AND IP 12
Results: 22
The immunosuppression pathway of tumor‐associated macrophages is controlled by heme oxygenase‐1 in glioblastoma patients.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2265, doi. 10.1002/ijc.34270
- By:
- Publication type:
- Article
ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2161, doi. 10.1002/ijc.34257
- By:
- Publication type:
- Article
Nuclear AREG affects a low‐proliferative phenotype and contributes to drug resistance of melanoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2244, doi. 10.1002/ijc.34254
- By:
- Publication type:
- Article
Dickkopf‐1 expression is repressed by oncogenic human papillomaviruses (HPVs) and regulates the Cisplatin sensitivity of HPV‐positive cancer cells in a JNK‐dependent manner.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2215, doi. 10.1002/ijc.34250
- By:
- Publication type:
- Article
Thy‐Wise: An interpretable machine learning model for the evaluation of thyroid nodules.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2229, doi. 10.1002/ijc.34248
- By:
- Publication type:
- Article
The presence of vessels encapsulating tumor clusters is associated with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2278, doi. 10.1002/ijc.34247
- By:
- Publication type:
- Article
Comments on "Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)".
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2291, doi. 10.1002/ijc.34246
- By:
- Publication type:
- Article
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2144, doi. 10.1002/ijc.34229
- By:
- Publication type:
- Article
The causal association between smoking, alcohol consumption and risk of bladder cancer: A univariable and multivariable Mendelian randomization study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2136, doi. 10.1002/ijc.34228
- By:
- Publication type:
- Article
National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population‐based cancer registries.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2128, doi. 10.1002/ijc.34224
- By:
- Publication type:
- Article
Identification of prediagnostic metabolites associated with prostate cancer risk by untargeted mass spectrometry‐based metabolomics: A case‐control study nested in the Northern Sweden Health and Disease Study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2115, doi. 10.1002/ijc.34223
- By:
- Publication type:
- Article
A cross‐sectional study of the FDA approved indications and supporting pivotal trials of small‐molecular kinase inhibitors in cancer therapies with the biomarker of cancer driver gene.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2107, doi. 10.1002/ijc.34222
- By:
- Publication type:
- Article
Person‐years of life lost and lost earnings from cigarette smoking‐attributable cancer deaths, United States, 2019.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2095, doi. 10.1002/ijc.34217
- By:
- Publication type:
- Article
Circulating plasma phospholipid fatty acid levels and breast cancer risk in the Cancer Prevention Study‐II Nutrition Cohort.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2082, doi. 10.1002/ijc.34216
- By:
- Publication type:
- Article
Improved survival and higher rates of surgical resection associated with hepatocellular carcinoma in children as compared to young adults.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2206, doi. 10.1002/ijc.34215
- By:
- Publication type:
- Article
PPARgamma agonism inhibits progression of premalignant lesions in a murine lung squamous cell carcinoma model.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2195, doi. 10.1002/ijc.34210
- By:
- Publication type:
- Article
Randomized multicenter phase II trial of prophylactic irradiation of para‐aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07‐01) study.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2182, doi. 10.1002/ijc.34190
- By:
- Publication type:
- Article
DNA methylation biomarkers in colorectal cancer: Clinical applications for precision medicine.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2068, doi. 10.1002/ijc.34186
- By:
- Publication type:
- Article
Association of germline TYK2 variation with lung cancer and non‐Hodgkin lymphoma risk.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2155, doi. 10.1002/ijc.34180
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2061, doi. 10.1002/ijc.33670
- Publication type:
- Article
Multicenter, single‐arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild‐type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell‐free DNA
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2172, doi. 10.1002/ijc.34184
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2293, doi. 10.1002/ijc.33669
- Publication type:
- Article